INTRODUCTION
============

Voltage-gated Ca^2+^ (Ca~V~) channels initiate excitation-contraction coupling in muscle cells, excitation-transcription coupling in neurons, and many other physiological events ([@bib39]; [@bib3]; [@bib2]; [@bib44]). In skeletal and cardiac muscle, up-regulation of the activity of Ca~V~1.1 and Ca~V~1.2 channels increases contractile force in response to activation of the β-adrenergic signaling pathway in the fight or flight response ([@bib40]; [@bib43]; [@bib4]). In neurons, activation of the dopamine and β-adrenergic signaling pathways increases Ca~V~1.2 channel activity and modulates gene transcription and synaptic plasticity ([@bib34]; [@bib20]; [@bib38]). β-Adrenergic receptors activate adenylyl cyclase, increase cAMP, activate cAMP-dependent protein kinase (PKA), and phosphorylate Ca~V~1.1 and Ca~V~1.2 channels ([@bib40]; [@bib43]; [@bib4]). Targeting PKA to specific subcellular cellular compartments or substrates by binding to A-kinase anchoring proteins (AKAPs) exerts spatiotemporal control over these regulatory processes ([@bib45]).

Ca~V~1.1 and Ca~V~1.2 channels form autoinhibitory signaling complexes, which are essential for regulation of their activity by the PKA pathway ([@bib27]; [@bib5]). Their pore-forming α~1~ subunits are proteolytically processed in vivo near the center of their large intracellular C-terminal domains ([@bib8], [@bib9], [@bib10]; [@bib24]). The membrane-anchored AKAP15/18^1^ ([@bib21], [@bib22]; [@bib13]) binds to the distal C-terminal domain (DCT; Ca~V~1.2\[1801--2122\]) of these channels via a modified leucine zipper motif ([@bib25], [@bib26]). The DCT and AKAP binding are required for regulation of Ca~V~1.1 and Ca~V~1.2 channels by PKA in skeletal and cardiac myocytes ([@bib22]; [@bib25], [@bib26]; [@bib18]; [@bib15]). Moreover, the proteolytically cleaved DCT binds to the remainder of the Ca~V~1.1 and Ca~V~1.2 channels by interaction with a site in the proximal C-terminal domain ([@bib28], [@bib29]) and is a potent autoinhibitor of the activity of Ca~V~1.2 channels when coexpressed in nonmuscle cells ([@bib29]). Activation of protein phosphorylation by PKA increases ion conductance activity by relieving the autoinhibitory effect of the DCT ([@bib17]).

Regulation of Ca~V~1.2 channels by PKA has been reconstituted by coexpression of the components of this autoinhibitory signaling complex in transfected cells ([@bib17]). Ca~V~1.2Δ1800 truncated at the site of in vivo proteolytic processing ([@bib12]) and the DCT composed of Ca~V~1.2\[1801--2122\] interact with each other when expressed as separate proteins, and the DCT markedly inhibits Ca~V~1.2 channel activity ([@bib29]; [@bib17]). Coexpression of these two components of the α1 subunit as separate proteins together with the auxiliary α2δ and β subunits of Ca~V~1.2 channels and AKAP15 yields an autoinhibited Ca~V~1.2 signaling complex whose activity can be increased three- to fourfold by activation of adenylyl cyclase in transfected cells ([@bib17]). Normal regulation of basal activity requires phosphorylation of Ser1700 and Thr1704, located at the interface between the DCT and the proximal C-terminal domain, and up-regulation of Ca~V~1.2 channel activity requires PKA phosphorylation of Ser1700 ([@bib17]). Cardiac myocytes from mice in which these sites are mutated to Ala have reduced basal L-type Ca^2+^ current and impaired up-regulation by β-adrenergic agonists, confirming the crucial role of this regulatory mechanism in vivo ([@bib16]).

AKAP15 also binds to Ca~V~1.2 channels in brain neurons ([@bib35]), and AKAP79/150^1^ binds to Ca~V~1.2 channels in both brain and cardiac muscle ([@bib19]; [@bib23]). Both of these AKAPs are involved in regulation of gene expression in response to activation of Ca~V~1.2 channels in neurons ([@bib36]; [@bib35]). The effects of AKAP79 on gene transcription in neurons are mediated by the Ca^2+^-regulated phosphoprotein phosphatase calcineurin, which binds directly to AKAP79 ([@bib36]). Like AKAP15, AKAP79 binds to Ca~V~1.2 channels via the modified leucine zipper motif in the DCT ([@bib36]). Therefore, it is of great interest to explore PKA regulation of Ca~V~1.2 channels mediated via AKAP79 compared with AKAP15 in our reconstituted regulatory system. Here we report strikingly different regulatory properties of these two AKAPs, which depend on binding of the phosphoprotein phosphatase calcineurin by AKAP79. Our results introduce an unexpected mode of differential regulation by AKAPs, in which different AKAPs can compete for binding at a single site and confer differential regulatory effects on the target protein by association with different signaling proteins.

MATERIALS AND METHODS
=====================

cDNA constructs
---------------

Constructs used in this study include rabbit α1.2a, rat β2b, rabbit α2δ1, AKAP15, AKAP79, PKA-Cα, and PKA-RIIα in pcDNA3 ([@bib17]). Ca~V~1.2 leucine zipper motif triple mutant (I2073A, F2080A, I2087A) was constructed using PCR overlap extension. Construction of AKAP~LZM~ was previously described ([@bib25]). AKAP79ΔPIX was provided by J.D. Scott (University of Washington, Seattle, WA). The mutant sequence, orientation, and reading frame of all constructs were confirmed by DNA sequencing.

Cell culture and transfection
-----------------------------

Human embryonic kidney tsA-201 cells were cultured in DMEM/Ham's F12 supplemented with 10% FBS and 100 U/ml penicillin and streptomycin. Cells were grown to ∼70% confluence in 10% CO~2~ and transiently transfected with cDNAs encoding α1.2a truncated at Ala1800 (Ca~V~1.2Δ1800), β2b, and α2δ1 subunits at a 1:1:1 molar ratio using the FuGENE 6 method (Roche). Wild-type or mutant DCT constructs composed of Ca~V~1.2(1801--2271) were transfected with Ca~V~1.2Δ1800 using a molar ratio of 0.75:1 (DCT/Ca~V~1.2Δ1800). In addition, cDNA encoding eGFP in the pcDNA3 vector was added at a molar ratio of 0.1:1 to each transfection mixture as an indicator of transfection efficiency.

Electrophysiology
-----------------

24 h after transfection, cells were plated at low density, and recordings were made 38--48 h after transfection using the whole-cell configuration of the patch clamp technique. Patch pipettes (1.5--2 MΩ) were pulled from micropipette glass (VWR Scientific) and fire-polished. Currents were recorded with an Axopatch 200B amplifier (Axon Instruments Inc.) and sampled at 5 kHz after anti-alias filtering at 2 kHz. Data acquisition and command potentials were controlled by either pCLAMP or HEKA Pulse software, and data were stored for later offline analysis. Voltage protocols were delivered at 10-s intervals, and leak and capacitive transients were subtracted using a *P*/4 protocol. Approximately 80% of series resistance was compensated with the patch clamp circuitry. The extracellular bath solution contained (mM) 150 Tris, 10 glucose, 1 MgCl~2~, and 10 BaCl~2~ (adjusted to pH 7.4 with CH~3~SO~3~). The intracellular solution contained (mM) 135 CsCl~2~, 10 EGTA, 1 MgCl~2~, 4 MgATP, and 10 HEPES (pH 7.3, adjusted with CsOH).

Analysis of electrophysiological recordings of Ca~V~1.2 channels
----------------------------------------------------------------

Current-voltage relationships from peak inward Ba^2+^ currents were normalized to gating charge (*Q*) to correct for variation in protein abundance. Gating currents result from the voltage-driven movement of gating charges as conformational changes occur preceding channel opening and are independent of channel unitary conductance and open probability (P~O~). Gating charge movement was measured as the integral of the gating current transient at the reversal potential of the ionic current ([Fig. S1](http://www.jgp.org/cgi/content/full/jgp.201311075/DC1){#supp1}). The reversal potential was determined by applying a series of test pulses at 10-s intervals from the holding potential of −80 mV to potentials between 60 and 80 mV in 2-mV increments. The ionic current that flows upon repolarization (the tail current) gives a functional readout proportional to the number of open channels, the single channel conductance, and channel P~O~ at the end of the depolarizing step. By comparing the ionic and gating currents we determined the efficiency of coupling of the charge movement of the voltage sensors to the subsequent opening of the pore by calculating the ratio of tail current to gating charge (tail current \[nA\]/integrated gating charge \[pC\]). Tail currents were recorded after repolarization to −50 mV after each test pulse. All data are expressed as means ± SEM of *n* cells. Bar graphs are presented for coupling ratio data in the figures, and scatter plots containing all of the individual cell values are presented for representative experiments in [Fig. S2](http://www.jgp.org/cgi/content/full/jgp.201311075/DC1){#supp2}. Statistical significance was tested with Student's *t* test for pairwise analysis and ANOVA followed by Dunnett's test for comparison of multiple conditions.

Online supplemental material
----------------------------

Fig. S1 illustrates the approach used for precise determination of the reversal potential and measurement of gating charge at that potential. Fig. S2 illustrates the coupling ratio data for individual cells that contribute to the means for representative experiments. Online supplemental material is available at <http://www.jgp.org/cgi/content/full/jgp.201311075/DC1>.

RESULTS
=======

Differential regulation of Ca~V~1.2 channels by association with AKAP15 versus AKAP79
-------------------------------------------------------------------------------------

Neurons, myocytes, and other excitable cells express a broad array of AKAPs, which are involved in many aspects of cell signaling ([@bib33]). AKAP15 and AKAP79 are both expressed in nerve and muscle cells and interact with a common regulatory site on Ca~V~1.2 channels in those cell types ([@bib21], [@bib22]; [@bib26], [@bib29]; [@bib23]; [@bib36]; [@bib35]). We used reconstitution of Ca~V~1.2 regulation in transfected cells to compare the effects of these two AKAPs on regulation of Ca~V~1.2 channels via the PKA pathway, and we recorded barium currents (I~Ba~) conducted by Ca~V~1.2 channels to minimize activation of Ca^2+^-dependent regulatory processes. Human embryonic kidney tsA-201 cells were cotransfected with Ca~V~1.2Δ1800, DCT, and Ca^2+^ channel auxiliary subunits, plus either AKAP15 or AKAP79 ([Fig. 1](#fig1){ref-type="fig"}). Cells transfected with Ca~V~1.2Δ1800 without DCT conducted high levels of I~Ba~ upon depolarization in whole-cell voltage clamp ([Fig. 1](#fig1){ref-type="fig"}, A \[top\] and B). In contrast, cells transfected with Ca~V~1.2Δ1800 + DCT had much lower levels of I~Ba~, reflecting the autoinhibitory effect of the DCT ([Fig. 1](#fig1){ref-type="fig"}, A \[top\] and B). The autoinhibitory effect of the DCT was also observed in measurements of the coupling ratio of ion channel opening to gating charge movement, which was calculated from measurements of gating charge movement at the reversal potential and tail currents immediately after repolarization ([Fig. 1](#fig1){ref-type="fig"}, A \[bottom\] and C). This measurement is unaffected by the efficiency of transfection and expression of the Ca~V~1.2 channels because it is a ratio of ionic current to gating charge for channels at the cell surface. The coupling ratio (I~Tail~/Q~Vrev~) was ∼45 nA/pC for Ca~V~1.2Δ1800 alone and 15 nA/pC for Ca~V~1.2Δ1800 + DCT ([Fig. 1 C](#fig1){ref-type="fig"}), as we have observed in previous work ([@bib17]).

![Differential PKA-dependent regulation of Ca~V~1.2Δ1800 channels via AKAP15 and AKAP79. (A) Representative I~Ba~ through Ca~V~1.2Δ1800 and Ca~V~1.2Δ1800 + DCT channels coexpressed with cDNA ratios of either 0.003:1 AKAP15 or 0.01:1 AKAP79 in tsA-201 cells in the absence or presence of 5 µM forskolin (Fsk) elicited by test pulses ranging from −60 to 10 mV (top) or test pulses to Vrev (bottom) from a holding potential of −80 mV. (B) Mean current-voltage relationships for Ca~V~1.2Δ1800 and Ca~V~1.2Δ1800 + DCT channels with 0.003:1 AKAP15 or 0.01:1 AKAP79 and 5 µM forskolin. (C) Coupling ratio (nA/pC) for Ca~V~1.2Δ1800 and Ca~V~1.2Δ1800 + DCT channels with AKAP15 or AKAP79 at the indicated ratios, without and with 5 µM forskolin. Dashed line indicates mean current for unstimulated Ca~V~1.2Δ1800 + DCT. *n* values and ±SEM are indicated. \*\*, P \< 0.01 versus control. Significance was determined by ANOVA followed by Dunnett's post-test. (D) Mean current-voltage relationships for Ca~V~1.2Δ1800 and Ca~V~1.2Δ1800 + DCT channels with 0.003:1 AKAP15 or 0.01:1 AKAP79 and 5 µM forskolin in the presence of PKA expressed at 1:1 cDNA ratio. (B and D) Error bars are SEM. (E) Coupling ratio (nA/pC) for Ca~V~1.2Δ1800 and Ca~V~1.2Δ1800 + DCT channels with AKAP15 or AKAP79, without and with 5 µM forskolin, in the presence of PKA expressed at 1:1 cDNA ratio. Dashed line indicates mean coupling ratio for unstimulated Ca~V~1.2Δ1800 + DCT. *n* values and ±SEM are indicated. \*\*, P \< 0.01 versus control. Significance was determined by Student's *t* test. The reversal potentials determined in these experiments did not vary significantly between groups (P \> 0.7).](JGP_201311075R_Fig1){#fig1}

We used 5 µM forskolin to activate adenylyl cyclase and the PKA signaling pathway. Activation of adenylyl cyclase with forskolin gave a substantial increase in I~Ba~ and coupling ratio for Ca~V~1.2Δ1800 + DCT coexpressed with an optimal level of AKAP15 ([Fig. 1, A--C](#fig1){ref-type="fig"}). We have shown previously that this increase results from phosphorylation of Ser1700 in Ca~V~1.2Δ1800 by PKA ([@bib17]). In contrast, forskolin treatment of Ca~V~1.2Δ1800 + DCT coexpressed with AKAP79 over a wide range of cDNA ratios did not result in an increase of either I~Ba~ or coupling ratio ([Fig. 1, A--C](#fig1){ref-type="fig"}), even though AKAP79 is known to bind to the AKAP-binding site in the DCT of Ca~V~1.2 channels ([@bib36]). To assure that PKA was not limiting in these experiments, we overexpressed PKA as described previously ([@bib17]) and conducted a similar series of experiments ([Fig. 1, D and E](#fig1){ref-type="fig"}). Forskolin had no effect in the absence of any AKAP or in the presence of AKAP79, in contrast to the substantial increase in I~Ba~ and coupling ratio in the presence of AKAP15. These results reveal striking differential regulation of Ca~V~1.2 channels via the PKA pathway dependent on their association with AKAP15 versus AKAP79.

Functional competition of AKAP15 and AKAP79 in regulation of Ca~V~1.2 channels
------------------------------------------------------------------------------

If AKAP15 and AKAP79 both interact with the AKAP-binding domain in the DCT of Ca~V~1.2 channels, they should compete with each other for binding to that regulatory site and PKA regulation via AKAP15 should be inhibited by coexpression of AKAP79. To examine this point, we expressed Ca~V~1.2Δ1800 + DCT with AKAP15 + AKAP79 and measured regulation by activation of adenylyl cyclase with forskolin ([Fig. 2](#fig2){ref-type="fig"}). The results show that AKAP79 does indeed inhibit PKA regulation of Ca~V~1.2Δ1800 + DCT coexpressed with AKAP15, as measured by the amplitude of I~Ba~ and the coupling ratio ([Fig. 2](#fig2){ref-type="fig"}). One potential mechanism of competitive interaction between AKAP15 and AKAP79 would be competitive binding of PKA by AKAP79, which could potentially deplete the cellular pool of PKA. To rule out this possibility, we overexpressed PKA in the presence of the two AKAPs ([Fig. 2 C](#fig2){ref-type="fig"}). Even under these conditions, expression of AKAP79 substantially reduced PKA regulation of Ca~V~1.2Δ1800 + DCT via AKAP15 ([Fig. 2 C](#fig2){ref-type="fig"}). Together, these results demonstrate competitive regulation of Ca~V~1.2 channels by AKAP15 and AKAP79, dependent on their binding to the AKAP-binding domain in the DCT.

![AKAP15 and AKAP79 compete for binding to the DCT of Ca~V~1.2 channels. (A) Representative I~Ba~ through Ca~V~1.2Δ1800 and Ca~V~1.2Δ1800 + DCT channels coexpressed with cDNA ratios of 0.003:1 WT AKAP15 and/or 0.01:1 AKAP79 in the presence of 5 µM forskolin (Fsk) elicited by a test pulse to 10 mV from a holding potential of −80 mV. (B) Mean current-voltage relationships for Ca~V~1.2Δ1800 and Ca~V~1.2Δ1800 + DCT channels coexpressed with 0.003:1 WT AKAP15 and/or 0.01:1 AKAP79 and 5 µM forskolin. Error bars are SEM. (C) Coupling efficiency (nA/pC) for Ca~V~1.2Δ1800 and Ca~V~1.2Δ1800 + DCT channels coexpressed with 0.003:1 WT AKAP15 and/or 0.01:1 AKAP79 and 5 µM forskolin. Dashed line indicates mean coupling ratio for unstimulated Ca~V~1.2Δ1800 + DCT. *n* values and mean ± SEM are indicated. \*\*, P \< 0.01 versus control. Significance was determined by ANOVA.](JGP_201311075_Fig2){#fig2}

Differential regulation requires calcineurin association with AKAP79
--------------------------------------------------------------------

One potential mechanism that could contribute to differential PKA regulation via AKAP15 and AKAP79 is the ability of AKAP79 to bind other signaling molecules and bring them into close association with Ca~V~1.2 channels ([@bib33]). In particular, AKAP79 binds the Ca^2+^-regulated phosphoprotein phosphatase calcineurin ([@bib6]; [@bib36]), which could dephosphorylate Ca~V~1.2 channels and reduce their up-regulation by PKA. Calcineurin binds to the PXIXIT motif on AKAP79 ([@bib11]; [@bib36]). Therefore, we examined regulation of Ca~V~1.2Δ1800 + DCT coexpressed with AKAP79 with the PXIXIT site deleted (AKAP79ΔPIX). Under these conditions, forskolin treatment increased the activity of Ca~V~1.2Δ1800 + DCT coexpressed with AKAP79ΔPIX as effectively as Ca~V~1.2Δ1800 + DCT coexpressed with AKAP15, when measured as the amplitude of I~Ba~ or the coupling ratio ([Fig. 3, A--C](#fig3){ref-type="fig"}). Overexpression of PKA further increased I~Ba~ and coupling ratio for Ca~V~1.2Δ1800 + DCT coexpressed with either AKAP79ΔPIX or AKAP15 ([Fig. 3, D and E](#fig3){ref-type="fig"}). Under experimental conditions similar to ours, [@bib36] found that competing peptide inhibitors of the binding of calcineurin to Ca~V~1.2 channels gave similar results as the ΔPIX mutation, indicating that the effects of this mutation are caused by inhibition of calcineurin binding and not by a more global conformational change in AKAP79. Moreover, our experiments show a gain of function effect of AKAP79ΔPIX, fully restoring its ability to support PKA regulation at the same level as AKAP15 ([Fig. 3 E](#fig3){ref-type="fig"}). Complete restoration of the activity of AKAP79 to the equivalent of AKAP15 would not be expected for a mutation-induced, nonspecific conformational change in AKAP79. Therefore, our results implicate binding of calcineurin to AKAP79 as the primary reason for its differential regulation of Ca~V~1.2 channels via the PKA pathway.

![PKA-dependent regulation of Ca~V~1.2Δ1800 channels via AKAP15 and AKAP79ΔPIX. (A) Representative I~Ba~ through Ca~V~1.2Δ1800 and Ca~V~1.2Δ1800 + DCT channels coexpressed with cDNA ratios of either 0.003:1 AKAP15 or 0.01:1 AKAP79ΔPIX in tsA-201 cells in the absence or presence of 5 µM forskolin elicited by a test pulse to 10 mV from a holding potential of −80 mV. (B) Mean current-voltage relationships for Ca~V~1.2Δ1800 and Ca~V~1.2Δ1800 + DCT channels with 0.003:1 AKAP15 or 0.01:1 AKAP79ΔPIX and 5 µM forskolin (Fsk). Dashed black line indicates zero current level. (C) Coupling efficiency (nA/pC) for Ca~V~1.2Δ1800 and Ca~V~1.2Δ1800 + DCT channels with AKAP15 or AKAP79ΔPIX and 5 µM forskolin. Dashed black line indicates mean coupling ratio for unstimulated Ca~V~1.2Δ1800 + DCT. *n* values and ±SEM are indicated. \*\*, P \< 0.01; and \*, P \< 0.05 versus control. Significance was determined by ANOVA followed by Dunnett's post-test. (D) Mean current-voltage relationships determined as in B. Fits to current-voltage relationships showed that there was no significant difference in the voltage dependence of activation (P \> 0.7). (B and D) Error bars are SEM. (E) Coupling ratio (nA/pC) for Ca~V~1.2Δ1800 and Ca~V~1.2Δ1800 + DCT channels with PKA Cα catalytic subunit plus PKA RIIα regulatory subunit, AKAP15, AKAP79ΔPIX, and 5 µM forskolin. Dashed black line indicates mean coupling ratio for unstimulated Ca~V~1.2Δ1800 + DCT. \*\*\*, P \< 0.001; and \*, P \< 0.05 versus controls without forskolin. Significance was determined by Student's *t* test. The control results for AKAP15 + DCT are values from the dataset published in [@bib17]. The experiments presented here overlapped in time with those previously published experiments.](JGP_201311075R_Fig3){#fig3}

Although calcineurin is strongly Ca^2+^ regulated, it has a significant basal activity ([@bib42]; [@bib37]; [@bib41]). In our experiments, we measure Ba^2+^ currents in low extracellular Ca^2+^ and we chelate intracellular Ca^2+^ with EGTA; therefore, it is likely that the basal activity of calcineurin in the presence of entering Ba^2+^ is sufficient to oppose PKA regulation in this experimental system. Consistent with this conclusion, we found that treatment with 5 µM cyclosporin A, which blocks up-regulation of calcineurin activity by Ca^2+^ without affecting basal activity ([@bib14]), did not significantly increase Ba^2+^ currents (P = 0.33). The mechanism of this effect of basal calcineurin activity on PKA regulation of Ca~V~1.2 channels is considered further in the Discussion.

AKAP15 and AKAP79ΔPIX require the modified leucine zipper motif in the DCT
--------------------------------------------------------------------------

AKAP15 binds to skeletal muscle Ca~V~1.1 channels and cardiac Ca~V~1.2 channels via a modified leucine zipper interaction between a heptad repeat of hydrophobic residues in the AKAP-binding domain in the DCT and a similar heptad repeat of two Leu residues in AKAP15, and this modified leucine zipper interaction is required for PKA regulation of Ca~V~1.2 channels in skeletal and cardiac myocytes ([@bib25], [@bib26]). To confirm that this leucine zipper interaction is also required for PKA regulation of Ca~V~1.2Δ1800 + DCT in our reconstituted regulatory system in transfected tsA-201 cells, we tested the regulatory effects of AKAP15~LZM~, in which the two Leu residues in heptad repeat in AKAP15 are mutated to Ala ([Fig. 4, A--C](#fig4){ref-type="fig"}). Our results show that AKAP15~LZM~ is completely ineffective in supporting PKA regulation of Ca~V~1.2Δ1800 + DCT, as measured by increased I~Ba~ or increased coupling ratio ([Fig. 4, A--C](#fig4){ref-type="fig"}). In complementary experiments, we substituted Ala for the three hydrophobic residues in the heptad repeat that forms the AKAP-binding domain in the DCT of Ca~V~1.2 channels to create the triple mutant DCT~LZM~. Coexpression of Ca~V~1.2Δ1800 + DCT~LZM~ with AKAP15 also resulted in loss of regulation via the PKA pathway ([Fig. 4, D--F](#fig4){ref-type="fig"}). These results confirm that PKA regulation via AKAP15 in our reconstituted system requires interaction of the leucine zipper motif in AKAP15 with the complementary modified leucine zipper motif in the DCT of Ca~V~1.2 channels.

![AKAP15 and AKAP79ΔPIX regulate Ca~V~1.2 channels through a modified leucine zipper motif located in the DCT. (A) Representative I~Ba~ through Ca~V~1.2Δ1800 and Ca~V~1.2Δ1800 + DCT channels coexpressed with cDNA ratios of 0.003:1 WT AKAP15 or AKAP15~LZM~ in the absence or presence of 5 µM forskolin (Fsk) elicited by a test pulse to 10 mV from a holding potential of −80 mV. (B) Mean current-voltage relationships for Ca~V~1.2Δ1800 and Ca~V~1.2Δ1800 + DCT channels coexpressed with cDNA ratios of 0.003:1 WT AKAP15 or AKAP15~LZM~ and 5 µM forskolin. (C) Coupling ratio (nA/pC) for Ca~V~1.2Δ1800 and Ca~V~1.2Δ1800 + DCT channels with WT AKAP15 or AKAP15~LZM~, without and with 5 µM forskolin. Dashed black line indicates mean coupling ratio for unstimulated Ca~V~1.2Δ1800 + DCT with AKAP15~LZM~. \*\*, P \< 0.01 versus control. (D) Representative I~Ba~ through Ca~V~1.2Δ1800 channels coexpressed with WT DCT or DCT~LZM~ and a cDNA ratio of 0.003:1 WT AKAP15 in the absence or presence of 5 µM forskolin. (E) Mean current-voltage relationships for Ca~V~1.2Δ1800 channels coexpressed with either WT DCT or DCT~LZM~ and a cDNA ratio of 0.003:1 WT AKAP15 without or with 5 µM forskolin. (F) Coupling efficiency (nA/pC) for Ca~V~1.2Δ1800 channels in E. Dashed line indicates mean coupling ratio for unstimulated Ca~V~1.2Δ1800 + DCT~LZM~ with AKAP15. \*\*, P \< 0.01 versus control. (G) Representative I~Ba~ through Ca~V~1.2Δ1800 channels coexpressed with WT DCT or DCT~LZM~ and 0.01:1 AKAP79ΔPIX in the absence or presence of 5 µM forskolin. (H) Mean current-voltage relationships for Ca~V~1.2Δ1800 channels with either WT DCT or DCT~LZM~, a cDNA ratio of 0.01:1 AKAP79ΔPIX, and 5 µM forskolin. (B, C, E, F, and H) Error bars are SEM. (I) Coupling ratio (nA/pC) for Ca~V~1.2Δ1800 channels in H. Dashed line indicates mean coupling ratio for unstimulated Ca~V~1.2Δ1800 + DCT~LZM~ with AKAP79ΔPIX. *n* values and means ± SEM are indicated. \*\*, P \< 0.01 versus control. Significance was determined by ANOVA.](JGP_201311075R_Fig4){#fig4}

Although AKAP79 is known to interact with Ca~V~1.2 channels via the modified leucine zipper motif in the DCT ([@bib23]; [@bib36]), the role of this interaction in up-regulation of ion conductance activity of Ca~V~1.2 channels has not been directly tested. Our ability to reconstitute PKA regulation of Ca~V~1.2 channels by coexpression with AKAP79ΔPIX in transfected cells now allows a direct test of its site of interaction using the DCT~LZM~ mutant. We found that Ca~V~1.2Δ1800 + DCT~LZM~ coexpressed with AKAP79ΔPIX was not up-regulated by activation of adenylyl cyclase with forskolin ([Fig. 4, G and H](#fig4){ref-type="fig"}). These results show directly that the regulatory effects of AKAP79ΔPIX, as well as those of AKAP15, require interaction with the modified leucine zipper motif in the DCT of Ca~V~1.2 channels.

DISCUSSION
==========

Reconstitution of regulation of Ca~V~1.2 channels by the PKA signaling pathway
------------------------------------------------------------------------------

The results presented here further establish the relevance of our reconstitution system for studies of regulation of Ca~V~1.2 channels by the PKA signaling pathway. Coexpression of different members of the autoinhibitory signaling complex formed by Ca~V~1.2 channels allows their differential regulatory properties to be directly determined and compared with the properties of Ca~V~1.2 channels expressed with AKAP15. Using this approach, we have found that AKAP79 confers strikingly different regulation from AKAP15. These results imply that differential expression and localization of AKAP15 and AKAP79 can lead to differential regulation of Ca~V~1.2 channels in different cell types and subcellular compartments. Our results highlight the importance of binding of the Ca^2+^-regulated phosphoprotein phosphatase calcineurin in determining the regulatory properties of AKAP79. A previous study has demonstrated its role in regulation of basal activity of Ca~V~1.2 channels and in regulation of gene expression via entry of Ca^2+^ through Ca~V~1.2 channels ([@bib36]). Our results provide direct evidence for an important role for calcineurin bound to AKAP79 in opposing up-regulation of Ca~V~1.2 channel function by the PKA pathway. A recent study shows that AKAP79 also binds phosphoprotein phosphatase-1 ([@bib31]), which may contribute additional modes of differential regulation of Ca~V~1.2 channels and other PKA signaling targets.

Differential regulation of Ca~V~1.2 channels by PKA bound to different AKAPs
----------------------------------------------------------------------------

Most cells express several different AKAPs, which have been shown to participate in many different cell signaling pathways ([@bib33]). Thus, differential regulation of distinct signaling pathways by different AKAPs is well established. Our results with Ca~V~1.2 channels add a new perspective on the potential molecular mechanisms for differential regulation by AKAPs by revealing that multiple AKAPs can bind at a single regulatory site on their common target protein and have differential effects on the same cell signaling pathway that are mediated by their associations with different regulatory proteins. AKAP15 and AKAP79 have previously been shown to interact with the same, short modified leucine zipper motif, which is required for their binding and support of PKA regulation ([@bib25], [@bib26]; [@bib36]). However, it was unknown whether interaction with this common site would cause functional competition between the two proteins. We found that AKAP15 and AKAP79 do indeed compete functionally when coexpressed with Ca~V~1.2 channels in the autoinhibitory signaling complex. Moreover, this functional competition is caused by the ability of AKAP79 to bind calcineurin. Because different AKAPs bind many different kinases, phosphoprotein phosphatases, and other signaling proteins ([@bib33]), this form of functional competition and differential regulation of target proteins by different AKAPs acting at a common binding site would provide a broad range of regulatory options controlled by expression and localization of AKAPs. These findings add an additional layer of flexibility and complexity to cell signaling pathways in which AKAPs organize multiple regulatory proteins.

Our results demonstrating functional competition among AKAPs interacting with the same site on Ca~V~1.2 channels take on additional significance in light of recent mouse genetic studies of AKAP regulation of the heart ([@bib30]). Deletion of both AKAP15 and AKAP79 in mice is not sufficient to prevent β-adrenergic up-regulation of Ca~V~1.2 channel activity by isoproterenol in ventricular myocytes ([@bib30]). Because β-adrenergic stimulation in ventricular myocytes requires AKAP anchoring at the AKAP-binding domain on Ca~V~1.2 channels ([@bib26]), these mouse genetic results imply that one or more additional AKAPs besides AKAP15 and AKAP79 can mediate β-adrenergic stimulation of Ca~V~1.2 channels in ventricular myocytes through interaction with the same site. Thus, functional competition for regulation of Ca~V~1.2 channels by AKAPs likely extends to at least one more, yet-unidentified AKAP. The levels of expression and affinity and the different regulatory properties of these AKAPs will determine which one is dominant in regulating Ca~V~1.2 channels and therefore will define the overall pattern of regulation of channel activity. Changes in expression of these AKAPs in different physiological and/or pathophysiological states may be important determinants of the activity of Ca~V~1.2 channels.

Regulation of Ca~V~1.2 channels by calcineurin bound to AKAP79
--------------------------------------------------------------

Differential regulation of Ca~V~1.2 channels by AKAPs might reflect altered interactions between the channel and AKAP or differential interactions of the bound AKAP with other signaling proteins. Our results with AKAP79 show that its binding of calcineurin is responsible for its inability to support PKA regulation of Ca~V~1.2 channels. Surprisingly, the basal phosphatase activity of calcineurin is sufficient for this regulatory effect. Our measurements are made using Ba^2+^ as the permeant ion, and intracellular Ca^2+^ is strongly buffered with EGTA in the recording pipette. Therefore, it is unlikely that calcineurin is substantially up-regulated by Ca^2+^ binding in our experiments. Calcineurin has a significant basal activity, which is ∼0.25--1% of its maximal activity when fully activated by Ca^2+^ and calmodulin in biochemical assays in solution ([@bib42]; [@bib37]; [@bib41]). The rate of dephosphorylation of phosphoprotein substrates depends on their local concentration in the vicinity of the phosphatase, and tethering of calcineurin directly to the DCT of Ca~V~1.2 channels would increase the local concentration of its substrate site at Ser1700-P by hundreds or thousands of fold. Evidently, the effect of proximity afforded by binding to AKAP79 allows effective dephosphorylation of the Ca~V~1.2 channel by the basal activity of calcineurin at a rate that is comparable with or greater than the rate of phosphorylation by PKA, preventing accumulation of phosphorylated Ca~V~1.2 channels and resulting in functional competition between AKAP15 and AKAP79 at their common binding site. In a cardiac myocyte, increases of cAMP near Ca~V~1.2 channels may be faster and larger because of localized signaling; therefore, activation of calcineurin by Ca^2+^ entering through Ca~V~1.2 channels may be required to return the activity of these channels to the basal level in vivo. These considerations further emphasize the importance of a signaling complex for regulation of Ca~V~1.2 channels in vivo.

Regulation of Ca~V~1.2 channels in different tissues
----------------------------------------------------

Ca~V~1.2 channels conduct L-type Ca^2+^ currents in several different cell types. In skeletal and cardiac myocytes, up-regulation of Ca~V~1.2 channel activity in response to activation of the β-adrenergic signaling pathway contributes to the increase in contractile force during the fight or flight response ([@bib40]; [@bib43]; [@bib3]). In brain neurons, Ca~V~1.2 channels are involved in synaptic plasticity on the postsynaptic side of the synapse, and up-regulation of their activity by the β-adrenergic and dopaminergic signaling pathways enhances synaptic transmission ([@bib7]; [@bib47]; [@bib23]). In endocrine cells, Ca~V~1.2 channels mediate Ca^2+^ entry that triggers secretion of hormones, and regulation by the PKA signaling pathway is an important regulator of hormone release ([@bib1]; [@bib46]). AKAP15 and AKAP79 can regulate Ca~V~1.2 channels in skeletal and cardiac myocytes ([@bib25], [@bib26]) and brain neurons ([@bib23]; [@bib35]), and AKAPs are also implicated in control of hormone secretion ([@bib32]; [@bib46]). Our results presented here imply that competitive binding of AKAP15, AKAP79, and potentially other AKAPs at the AKAP-binding domain on Ca~V~1.2 channels can transform the regulatory responses of Ca~V~1.2 channels to the PKA signaling pathway and potentially to other intracellular signaling pathways and thereby can fine-tune the regulation of muscle contraction, synaptic transmission, and hormone secretion.
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